DalsnaFinance

Albany ENT & Allergy Services' Chief Strategy Officer Selected as ASCENT 2027 President-Elect

Markets PR Newswire By PR Newswire 04 Jun 2026 12:34 1 min read
Albany ENT & Allergy Services' Chief Strategy Officer Selected as ASCENT 2027 President-Elect

ALBANY, N.Y., June 4, 2026 /PRNewswire/ -- Albany ENT & Allergy Services, PC is proud to announce that Chief Strategy Officer Drew Franklin has been selected as president-elect for 2027 of ASCENT, the national association supporting leadership and operational excellence for otolaryngology...

ALBANY, N.Y., June 4, 2026 /PRNewswire/ -- Albany ENT & Allergy Services, PC is proud to announce that Chief Strategy Officer Drew Franklin has been selected as president-elect for 2027 of ASCENT, the national association supporting leadership and operational excellence for otolaryngology...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.